Is increased D2 receptor availability associated with response to stimulant medication in ADHD

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Developmental Medicine & Child Neurology

• Publication date

  2001-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1469-8749.2001.tb00157.xPMID 11730150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo characterisation of 3-iodo-6-methoxybenzamide123I in humans

  2004cited by this paper
• Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels.

  1999cited by this paper
• High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.

  1999influential reference
• Dopamine transporter density in patients with attention deficit hyperactivity disorder.

  1999cited by this paper
• Molecular approaches to child psychopathology.

  1998cited by this paper
• Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.

  1998cited by this paper
• Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT.

  1998influential reference
• Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

  1997cited by this paper
• Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography

  1997cited by this paper
• Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.

  1997cited by this paper
• Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder.

  1996cited by this paper
• Dopamine D2 receptor binding is reduced in Wilson's disease: correlation of neurological deficits with striatal 123I-iodobenzamide binding.

  1996cited by this paper
• Basal Ganglia Volumes in Children With Attention-Deficit Hyperactivity Disorder

  1996cited by this paper
• Association of attention-deficit disorder and the dopamine transporter gene.

  1995cited by this paper
• Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys.

  1994cited by this paper
• Proposed animal model of attention deficit hyperactivity disorder.

  1994cited by this paper
• Imaging endogenous dopamine competition with [11C]raclopride in the human brain

  1994cited by this paper
• Brain metabolism in teenagers with attention-deficit hyperactivity disorder.

  1993cited by this paper
• Attention Deficit- Hyperactivity Disorder and Asymmetry of the Caudate Nucleus

  1993cited by this paper
• Decrease of D2 receptors indicated by 123I‐iodobenzamide single‐photon emission computed tomography relates to neurological deficit in treated Wilson's disease

  1992cited by this paper
• Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

  1991cited by this paper
• Wilson's Disease.

  1991cited by this paper
• High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.

  1991cited by this paper
• Cerebral glucose metabolism in adults with hyperactivity of childhood onset.

  1990cited by this paper
• In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.

  1990cited by this paper
• In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.

  1989cited by this paper
• Dopamine receptors in human brain: autoradiographic distribution of D2 sites.

  1989cited by this paper
• Attention deficit disorder in childhood.

  1987cited by this paper
• Normative data on Revised Conners Parent and Teacher Rating Scales

  1978influential reference
• Conners' Teacher Rating Scale for use in drug studies with children — An empirical study

  1975cited by this paper
• A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.

  1972cited by this paper
• Symptom Patterns in Hyperkinetic, Neurotic, and Normal Children.

  1970influential reference
• A teacher rating scale for use in drug studies with children.

  1969influential reference

• Modulatory effects of Hizikia fusiformis on the dopaminergic system in a neonatal habenular lesion-induced attention-deficit hyperactivity disorder-like rodent model

  2025cites this paper
• Molecular Docking, Bioinformatic Analysis, and Experimental Verification for the Effect of Naringin on ADHD: Possible Inhibition of GSK-3β and HSP90

  2024cites this paper
• FROM NEURONS TO BRAIN NETWORKS, PHARMACODYNAMICS OF STIMULANT MEDICATION FOR ADHD.

  2024cites this paper
• An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder

  2023cites this paper
• Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

  2022cites this paper
• Monoaminergic hypo- or hyperfunction in adolescent and adult attention-deficit hyperactivity disorder?

  2021cites this paper
• Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD

  2021cites this paper
• Responsivity of the striatal dopamine system to methylphenidate - a within-subject I-123-β-CIT-SPECT study in children and adolescents with Attention-Deficit/Hyperactivity Disorder

  2021cites this paper
• Effects of methylphenidate on height, weight and blood biochemistry parameters in prepubertal boys with attention deficit hyperactivity disorder: an open label prospective study

  2021cites this paper
• Cortico-basal ganglia circuits underlying dysfunctional control of motor behaviors in neuropsychiatric disorders.

  2020cites this paper
• Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.

  2020cites this paper
• The Effect of Methylphenidate (MPH) on Appetite, Energy Intake, and Body Composition in Individuals Living with Obesity: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

  2019cites this paper
• Availability of Striatal Dopamine Transporter in Healthy Individuals With and Without a Family History of ADHD

  2019cites this paper
• The influence of methylphenidate on heart rate and brain connectivity

  2018cites this paper
• Latent-Profile Analysis Reveals Behavioral and Brain Correlates of Dopamine-Cognition Associations

  2018cites this paper
• Brain imaging genetics in ADHD and beyond ‐ Mapping pathways from gene to disorder at different levels of complexity

  2017cites this paper
• Acute and long‐term effects of adolescent methylphenidate on decision‐making and dopamine receptor mRNA expression in the orbitofrontal cortex

  2017cites this paper
• Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder.

  2016cites this paper
• Imaging of ADHD examines changes in cerebral blood flow and glucose metabolism and concentrations of synaptic structures

  2015cites this paper
• Mesocorticolimbic dopamine functioning in primary psychopathy: A source of within-group heterogeneity.

  2015cites this paper
• Neuroimaging-Aided Prediction of the Effect of Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder: A Randomized Controlled Trial

  2015cites this paper
• Role of basolateral amygdala dopamine D2 receptors in impulsive choice in acute cocaine-treated rats.

  2015cites this paper
• [Neurobiology of attention deficit hyperactivity disorder].

  2014cites this paper
• Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD)

  2014cites this paper
• Striatal volume deficits in children with ADHD who present a poor response to methylphenidate

  2014cites this paper
• Neuroimaging markers for the prediction of treatment response to Methylphenidate in ADHD.

  2013cites this paper
• Pathophysiology of ADHD

  2013cites this paper
• Brain Imaging in Behavioral Neuroscience

  2012cites this paper
• Loss of striatal cannabinoid CB1 receptor function in attention‐deficit / hyperactivity disorder mice with point‐mutation of the dopamine transporter

  2011cites this paper
• The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.

  2011cites this paper
• Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits.

  2009influential citation
• A Critical Review of ADHD Neuroimaging Research

  2009cites this paper
• Positron emission tomography neuroimaging for a better understanding of the biology of ADHD.

  2009cites this paper
• Dikkat Eksikliði Hiperaktivite Bozukluðunda Nörogörüntüleme Yöntemleri

  2008cites this paper
• Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)‐S14297

  2008cites this paper
• Nuclear medicine applications in molecular imaging: 2007 update.

  2007cites this paper
• Studies on neurodevelopmental issues in children

  2007cites this paper
• Investigating the Dopaminergic Synapse In Vivo. I. Molecular Imaging Studies in Humans

  2007cites this paper
• La disminución volumétrica del núcleo caudado derecho como fenotipo neuroanatómico del trastorno por déficit de atención con hiperactividad pediátrico. Un análisis morfométrico fronto-caudado por resonancia magnética estructural

  2007cites this paper
• D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.

  2007cites this paper
• [Neuropsychiatric bases of the methylphenidate-therapy of the attention deficit/hyperactivity disorder (ADHD)].

  2007cites this paper
• Brain dopamine transporter levels in treatment and drug naïve adults with ADHD

  2007cites this paper
• Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.

  2007cites this paper
• Risperidone-to-methylphenidate switch reaction in children: three cases

  2006cites this paper
• Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism.

  2006cites this paper
• A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

  2006cites this paper
• Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology.

  2006cites this paper
• Neuropsychiatrie des Methylphenidat bei der Aufmerksamkeits-Defizit/Hyperaktivitäts-Störung (ADHS)

  2006cites this paper
• Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.

  2005cites this paper
• maging the Effects of Methylphenidate on Brain opamine: New Model on Its Therapeutic Actions for ttention-Deficit/Hyperactivity Disorder

  2005cites this paper
• Children with ADHD in a rural community

  2005cites this paper
• Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder

  2005cites this paper
• Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

  2005cites this paper
• Effect of preweanling methylphenidate exposure on the induction, extinction and reinstatement of morphine-Induced conditioned place preference in rats

  2005cites this paper
• Dynamic Dopamine Modulation of Striato-Cortical Circuits in Cognition: Converging Neuropsychological, Psychopharmacological and Computational Studies

  2004cites this paper
• ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow

  2004cites this paper
• ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow.

  2004cites this paper
• Molecular imaging with single photon emission computed tomography

  2004cites this paper
• Broken brains or flawed studies? A critical review of ADHD neuroimaging research.

  2003cites this paper
• Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

  2003cites this paper
• Thursday, May 8, 2003 (S38-S63)

  2003cites this paper
• Methylphenidate Down-Regulates the Dopamine Receptor and Transporter System in Children with Attention Deficit Hyperkinetic Disorder (ADHD)

  2003cites this paper
• Nuclear medicine applications in molecular imaging

  2002cites this paper
• [PET in neurology and psychiatry I. PET with FDG in the study of the CNS].

  2002cites this paper
• Responses to methylphenidate in Attention-Deficit/Hyperactivity Disorder and normal children: Update 2002

  2002cites this paper
• Proceed, with caution: SPECT cerebral blood flow studies of children and adolescents with attention deficit hyperactivity disorder.

  2002cites this paper